Patient survey shows challenges with affordability, activity limitations, mental health
Public Awareness Low for Invasive Fungal Diseases
Awareness varies from 4.1 percent for blastomycosis to 24.6 percent for candidiasis
FDA Requiring Labeling Changes to Benzodiazepine Prescribing Information
Update to Boxed Warning must include risks for abuse, misuse, addiction, physical dependence, withdrawal reaction
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Risk for Autism Increased With Preterm, Postterm Birth
Risk increased for children born in weeks 22 to 31, 32 to 36, 43 to 44 versus 37 to 42 of gestation
Most People With SARS-CoV-2 Do Not Remain Asymptomatic
Secondary attack rate lower for contacts of people with asymptomatic versus symptomatic infection
Oral Steroids May Raise Risks for Diabetes, HTN, VTE in Children
But absolute risks for these complications still low among children receiving glucocorticoids
Negative Pressure Does Not Cut C-Section Infection Risk in Obese
Findings do not support routine use of prophylactic negative pressure wound therapy in obese women
Metformin May Slow Cognitive Decline in Seniors With T2DM
Cognitive decline slower, dementia risk reduced in seniors with diabetes receiving metformin
Fewer Women Aware of Heart Disease as Leading Cause of Death
Among U.S. women, decrease in awareness seen for all races/ethnicities, all ages except ≥65 years